Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tan, Lih Y."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moldenhauer, Lachlan M., Cockshell, Michaelia P., Frost, Lachlan, Parham, Kate A., Tvorogov, Denis, Tan, Lih Y., Ebert, Lisa M., Tooley, Katie, Worthley, Stephen, Lopez, Angel F., Bonder, Claudine S.
Publikováno v:
In Stem Cell Research May 2015 14(3):380-395
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lih Y. Tan, Michaelia P. Cockshell, Eli Moore, Kay K. Myo Min, Michael Ortiz, M. Zahied Johan, Brenton Ebert, Andrew Ruszkiewicz, Michael P. Brown, Lisa M. Ebert, Claudine S. Bonder
Publikováno v:
Oncoimmunology. 11(1)
Refereed/Peer-reviewed The progression of cancer is facilitated by infiltrating leukocytes which can either actively kill cancer cells or promote their survival. Our current understanding of leukocyte recruitment into tumors is largely limited to the
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma
Autor:
Brenton W Ebert, Kay Khine Myo Min, Stuart M. Pitson, M. Zahied Johan, Claudine S. Bonder, Lih Y. Tan, Andrew C.W. Zannettino, Benjamin M Weimann, Kate Vandyke, Mark O. DeNichilo, Lisa M. Ebert, Craig T. Wallington-Beddoe
Multiple myeloma (MM) is the second most common haematological malignancy and is an incurable disease of neoplastic plasma cells (PC). Newly diagnosed MM patients currently undergo lengthy genetic testing to match chromosomal mutations with the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b75d38122ece05bdf21d4362b0b50b4
https://hdl.handle.net/11541.2/148240
https://hdl.handle.net/11541.2/148240
Autor:
Denis Tvorogov, Stephen G. Worthley, Angel F. Lopez, Claudine S. Bonder, Lih Y. Tan, L. Frost, Lachlan M. Moldenhauer, Michaelia P. Cockshell, Katie Tooley, Kate A. Parham, Lisa M. Ebert
Publikováno v:
Stem Cell Research, Vol 14, Iss 3, Pp 380-395 (2015)
Circulating endothelial progenitor cells (EPCs) provide revascularisation for cardiovascular disease and the expansion of these cells opens up the possibility of their use as a cell therapy. Herein we show that interleukin-3 (IL3) strongly expands a
Autor:
Simon A. Koblar, Stan Gronthos, Samantha E. Boyle, Kelly L. Betterman, Angel F. Lopez, Andrew C.W. Zannettino, Kate A. Parham, Michaelia P. Cockshell, Claudine S. Bonder, Kay Khine Myo Min, Angela Peng, YouFang F. Zhang, Natasha L. Harvey, Lokugan S. Silva, M. Zahied Johan, Mark Shackleton, Paceman Szeto, Lisa M. Ebert, Lih Y. Tan, Andrew Ruszkiewicz
Publikováno v:
Angiogenesis
Desmogleins (DSG) are a family of cadherin adhesion proteins that were first identified in desmosomes and provide cardiomyocytes and epithelial cells with the junctional stability to tolerate mechanical stress. However, one member of this family, DSG
Autor:
Ebert LM; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Vandyke K; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Myeloma Research Laboratory, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Johan MZ; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., DeNichilo M; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Tan LY; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Myo Min KK; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Weimann BM; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Ebert BW; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia., Pitson SM; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Zannettino ACW; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Myeloma Research Laboratory, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Wallington-Beddoe CT; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.; Flinders Medical Centre, Bedford Park, SA, Australia., Bonder CS; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Mar; Vol. 16 (6), pp. 1221-1240. Date of Electronic Publication: 2021 Jul 24.